Cargando…
AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
Mitochondrial diseases are a group of rare, heterogeneous diseases caused by gene mutations in both nuclear and mitochondrial genomes that result in defects in mitochondrial function. They are responsible for significant morbidity and mortality as they affect multiple organ systems and particularly...
Autores principales: | Hanaford, Allison R., Cho, Yoon-Jae, Nakai, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169410/ https://www.ncbi.nlm.nih.gov/pubmed/35668433 http://dx.doi.org/10.1186/s13023-022-02324-7 |
Ejemplares similares
-
AAV gene therapy vectors in the TMJ
por: Brouxhon, Sabine M., et al.
Publicado: (2022) -
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
por: Hacker, Ulrich T., et al.
Publicado: (2020) -
Evaluation of AAV-DJ vector for retinal gene therapy
por: Katada, Yusaku, et al.
Publicado: (2019) -
Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors
por: Eichhoff, Anna Marei, et al.
Publicado: (2019) -
The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence
por: Hanaford, Allison, et al.
Publicado: (2022)